Attogene is a biotechnology company dedicated to developing advanced sensing technologies for detecting compounds in a variety of samples. Founded with a mission to enhance diagnostic capabilities and improve public health outcomes, Attogene offers a range of products including RNase and DNase activity assay kits, viral detection kits for pathogens like SARS-CoV-2, Influenza, RSV, and Dengue virus. Their market focus spans clinical diagnostics, research laboratories, and public health institutions.
Notable figures associated with Attogene include experts in biotechnology and diagnostics, though specific names are not provided. The company has achieved significant milestones in the rapid development and deployment of diagnostic kits, particularly during the COVID-19 pandemic. Attogene's impact is evident in its contribution to timely and accurate disease detection, aiding in global health monitoring and response efforts.
